Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

PHOTOFINISH: a Clinical Study To Evaluate The Efficacy And Safety Of the System VULNOFAST® Plus/VULNOLIGHT® In Addition To The Usual Care (UC) Vs UC Alone For The Treatment Of Infected Diabetic Foot Ulcers

A legfontosabb adatok

Ki végzi
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
Hol
Olaszország7 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Befejeződött
Résztvevők
78 fő vett részt
Kezdés
2021. szept. 14.
Befejezés
2026. ápr. 7.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Usual Care alone
  • System VULNOFAST® plus / VULNOLIGHT® in addition to Usual Care
A regiszteradat frissítve
2026. november 3.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 23 feltétel megnézéseKevesebb

Egyéb feltételek

  • Main Inclusion Criteria:
  • Able and willing to give voluntary written informed consent. The ICF, must be signed before any study-related procedures and/or assessments are performed
  • Outpatients or inpatients (male and female) of any ethnic origin, aged 18 years or over, diagnosed with type 1 or type 2 diabetes mellitus
  • Glycaemic control confirmed by a glycated haemoglobin (HbA1c) levels ≤10% (86 mmol/mol), evaluated in the 3 months before enrolment or at Visit 1
  • Fasting plasma glucose (FPG) less than 300 mg/dl
  • A chronic diabetic foot ulcer (DFU) below the malleolus, with an area ≥ 2 and ≤ 40 cm2 and with a maximum diameter/length ≤ 10 cm measured by MolecuLight i:X medical device [note: chronic wound is defined as a wound that, after the normal clinical practice, does not start healing within 4 weeks or does not heal within 8 weeks]
  • A diabetic foot wound with a depth equal or higher to grade 2 according to the category "Depth/tissue loss" of PEDIS, but not involving bone, diagnosed by clinical examination
  • Presence of infected foot ulcer of grade 2 according to the category "Infection" of PEDIS, diagnosed by clinical examination
  • Able to take oral medications
  • Patients must be willing and able to comply with the protocol and study procedures; Main Exclusion Criteria:
  • Patients unable to give written informed consent
  • Females who are pregnant or lactating
  • Females who are of child bearing potential and not taking adequate contraceptive precautions are excluded from the trial. Females of child bearing potential taking acceptable contraceptive precautions can be included
  • Participation in any other clinical trial or currently receiving any other investigational product(s) within 30 days prior to Visit 1
  • Ankle brachial systolic blood pressure index < 0.5 (Winsor Index) in the infected limb
  • Ulcer probe to bone positive
  • Any surgery planned during the study period (from ICF signature to last planned follow-up visit)
  • Clinical diagnosis of peripheral vascular disease (PVD) requiring percutaneous or surgical revascularization
  • Transcutaneous oximetry (TcPo2) measurement < 30 mmHg
  • Use of any antibiotics (local or systemic) within 48h before Visit 1
  • Patient for whom punch biopsy is contraindicated
  • Patients that cannot take amoxicillin and clavulanic acid (background antibiotic therapy) at the dosage stated in the protocol and according to the current Summary of Product Characteristics (SPC)
  • Patients that cannot be treated with topical antiseptic containing Iodopovidone and/or with iodopovidone impregnated gauze according to the contraindication available in the current Summary of Product Characteristics (SPC)

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

The aim of this randomised, open-label, multicentre clinical trial is to evaluate the superiority of the treatment which foresees the addition of the system VULNOFAST® plus / VULNOLIGHT® to the Usual Care, versus the treatment with Usual Care alone, for the healing of chronic diabetic foot ulcer. VULNOFAST® plus is a sterile solution used in combination with a red light source VULNOLIGHT®. Usual Care is defined as procedures to apply to the foot ulcer, carried out in the order in which they are listed in the protocol.

A vizsgálat 2 csoportja

  • Arm A: Usual Care aloneMár használt kezelés, összehasonlításként

    Kezelés: Usual Care alone

  • Arm B: system VULNOFAST® plus / VULNOLIGHT® in addition to Usual CareA vizsgált kezelés

    Kezelés: System VULNOFAST® plus / VULNOLIGHT® in addition to Usual Care

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Randomised, Open-Label, Multicentre Clinical Study To Evaluate The Efficacy And Safety Of Topical Applications Of the System VULNOFAST® Plus / VULNOLIGHT® In Addition To The Usual Care Versus Usual Care Alone For The Treatment Of Infected Foot Ulcers In Diabetic Patients (PHOTOFINISH)
A regiszteradat frissítve
2026. november 3.